Pegfilgrastim biosimilar (Beijing SL Pharmaceutical)

培非格司亭生物类似药（北京双鹭药业）

Report date: 2023/10/23 16:17:14

Base Information

Drug NamePegfilgrastim biosimilar (Beijing SL Pharmaceutical)
Drug Alias Name非格司亭生物仿制药（北京双鹭药业）培非拉司亭生物仿制药（北京双鹭药业）培非格司亭生物仿制药（北京双鹭药业）聚乙二醇化人粒细胞刺激因子（北京双鹭药业）
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionHaematopoiesis stimulants
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaNeutropenia
Original Approved Country/TerritoryMainland China
Original Approved Date2023/09/19
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Sl Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A